VISA-Daptomycin non-susceptible Staphylococcus aureus frequently demonstrate non-susceptibility to Telavancin

被引:2
|
作者
Saravolatz, Louis D. [1 ]
Pawlak, Joan [1 ]
机构
[1] Ascens St John Hosp, Detroit, MI 48236 USA
关键词
Telavancin; Daptomycin; CLSI; Staphylococcus aureus; Methicillin-resistant Staphylococcus aureus; BROTH MICRODILUTION METHOD; IN-VITRO ACTIVITY; COLLECTION; VANCOMYCIN;
D O I
10.1016/j.diagmicrobio.2018.09.003
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Telavancin was evaluated against S. aureus isolates with reduced susceptibility to other antimicrobial agents using two broth microdilution methods and Etest (R) strips. The three methods provided comparable results. Differences in telavancin susceptibility versus non-susceptibility were noted mainly in the VISA-daptomycin non-susceptible group of isolates. In this group the percent susceptibility was 38% for the Etest (R) method and 50% and 54% for the 2 broth microdilution methods. All differences in susceptibility were within one 2-fold dilution. (C) 2018 Elsevier Inc. All rights reserved.
引用
收藏
页码:159 / 161
页数:3
相关论文
共 50 条
  • [1] Daptomycin non-susceptible Staphylococcus aureus at a US medical centre
    Velazquez, A.
    DeRyke, C. A.
    Goering, R.
    Hoover, V.
    Wallace, M. R.
    CLINICAL MICROBIOLOGY AND INFECTION, 2013, 19 (12) : 1169 - 1172
  • [2] Assessment of invitrosynergy of daptomycin or vancomycin plus ceftaroline for daptomycin non-susceptible Staphylococcus aureus
    Hutton, Mary A.
    Sundaram, Ayesha
    Perri, Mary B.
    Zervos, Marcus J.
    Herc, Erica S.
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2020, 98 (03)
  • [3] Metabolic interventions for the prevention and treatment of daptomycin non-susceptibility in Staphylococcus aureus
    Reed, Joseph M.
    Gardner, Stewart G.
    Mishra, Nagendra N.
    Bayer, Arnold S.
    Somerville, Greg A.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2019, 74 (08) : 2274 - 2283
  • [4] Increasing rate of daptomycin non-susceptible strains of Staphylococcus aureus in patients with atopic dermatitis
    Blazewicz, Izabela
    Jaskiewicz, Maciej
    Piechowicz, Lidia
    Neubauer, Damian
    Nowicki, Roman J.
    Kamysz, Wojciech
    Baranska-Rybak, Wioletta
    POSTEPY DERMATOLOGII I ALERGOLOGII, 2017, 34 (06): : 547 - 552
  • [5] Identification and comparison of risk factors for daptomycin non-susceptible S. aureus (DNS) and daptomycin non-susceptible Enterococcus (DNE)
    Cimino, Christo
    Slain, Douglas
    LaSala, Paul
    Keller, Lisa
    PHARMACOTHERAPY, 2015, 35 (11): : E275 - E275
  • [6] Evaluation of Daptomycin Non-Susceptible Staphylococcus aureus for Stability, Population Profiles, mprF Mutations, and Daptomycin Activity
    Steed M.E.
    Hall A.D.
    Salimnia H.
    Kaatz G.W.
    Kaye K.S.
    Rybak M.J.
    Infectious Diseases and Therapy, 2013, 2 (2) : 187 - 200
  • [7] Daptomycin non-susceptible meticillin-resistant Staphylococcus aureus USA 300 isolate
    Murthy, Madhukiran H.
    Olson, Michael E.
    Wickert, Robert W.
    Fey, Paul D.
    Jalali, Ziba
    JOURNAL OF MEDICAL MICROBIOLOGY, 2008, 57 (08) : 1036 - 1038
  • [8] Daptomycin non-susceptibility in vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous-VISA (hVISA): implications for therapy after vancomycin treatment failure
    Kelley, Peter G.
    Gao, Wei
    Ward, Peter B.
    Howden, Benjamin P.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2011, 66 (05) : 1057 - 1060
  • [9] Characterization of compensatory mutations associated with restoration of daptomycin-susceptibility in daptomycin non-susceptible methicillin-resistant Staphylococcus aureus and the role mprF mutations
    Kanesaka, Izumo
    Fujisaki, Shingo
    Aiba, Yoshifumi
    Watanabe, Shinya
    Mikawa, Takashi
    Katsuse, Akiko Kanayama
    Takahashi, Hiroshi
    Cui, Longzhu
    Kobayashi, Intetsu
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2019, 25 (01) : 1 - 5
  • [10] Phenotypic and genetic characterization of daptomycin non-susceptible Staphylococcus aureus strains selected by adaptive laboratory evolution
    Xu, Yanlei
    Xiao, Yanghua
    Zhao, Huilin
    Wang, Bingjie
    Yu, Jingyi
    Shang, Yongpeng
    Zhou, Ying
    Wu, Xiaocui
    Guo, Yinjuan
    Yu, Fangyou
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2024, 14